Cor­rect­ed: Bench­Sci rais­es $70M Se­ries D for drug dis­cov­ery soft­ware; Zen­tal­is touts PhIb ovar­i­an can­cer da­ta

Cana­da’s Bench­Sci has raised $70 mil­lion in a Se­ries D round de­signed to scale its AI drug dis­cov­ery plat­form for sci­en­tists work­ing in pre­clin­i­cal re­search.

The com­pa­ny boasts thou­sands of clients for its soft­ware, in­clud­ing 16 of the top 20 phar­ma­ceu­ti­cal com­pa­nies. On the plat­form, re­searchers can get a di­gest of AI’s sum­ma­ry of med­ical, clin­i­cal and re­search da­ta — help­ing them spot bi­o­log­i­cal con­nec­tions and choose among thou­sands of op­tions with, say, a reagent or an­ti­body.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER